News
Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...
Getting access to popular weight loss drugs will be simpler and cheaper for some.Health insurer Cigna (CI) announced a new ...
Investing.com -- Cigna’s Evernorth has introduced a new pharmacy benefit that caps out-of-pocket costs for GLP-1 weight loss ...
The focus of the lawsuit is forfeited funds, which total the amount of employer match contributions participants lose if they ...
The company and other insurers have faced backlash from patients who say they were denied necessary care and providers say ...
Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...
Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.
U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...
Just because a stock has been stagnant for a while doesn't mean the stagnation will continue. Here are five "Do-Nothing" ...
8h
GlobalData on MSNWegovy and Zepbound costs capped at $200 in new Evernorth programmeEvernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy ...
Mental health care is more important today than ever before. In New Jersey, many individuals and families are seeking accessible and affordable therapy options that provide long-term healing. Whether ...
"We are very pleased with the court’s decision, which affirms that IDR awards are enforceable and cannot be ignored by health plans and insurance companies," Adam T. Schramek of Norton Rose Fulbright, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results